Alexander Satchie

Alexander Satchie began their career in 2016 as a Researcher at the Johannsen Lab. In the same year, they were also a Researcher at the Vereide Group (Thomson Lab), where they developed CRISPR/cas9 protocols for effective ablation in endothelial cells and studied endothelial-to-mesenchymal transition. In 2019, they became an Emergency Medical Technician at Paratech Ambulance Service Inc. In 2021, they joined Invenra as a Senior Research Associate, where they performed +1000 transfections, generated 10+ cell lines, selecting and proliferating T cells and NK cells from PBMCs, and ran various assays (immune: proliferation, cytotoxicity, phagocytosis; molecular: MSD, ELISA). Alexander also developed a NK cytotoxicity assay to demonstrate antibody effectiveness against a confidential immune checkpoint. Alexander analyzed data with PRISM and FlowJo.

Alexander Satchie completed a Bachelor's degree in Biochemistry from the University of Wisconsin-Madison between the years 2015 and 2019.